SEELSEELOS THERAPEUTICS, INC.

Nasdaq seelostherapeutics.com


$ 0.19 $ -0.01 (-6.65 %)    

Thursday, 12-Sep-2024 15:59:43 EDT
QQQ $ 473.96 $ 0.54 (0.11 %)
DIA $ 414.09 $ 1.46 (0.35 %)
SPY $ 561.13 $ 0.86 (0.15 %)
TLT $ 100.32 $ -0.17 (-0.16 %)
GLD $ 238.45 $ 0.86 (0.36 %)
$ 0.1895
-- x --
-- x --
-- - --
$ 0.18 - $ 242.40
347,930
na
1.13M
$ 1.37
$ 0.28
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-10-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-04-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 03-11-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-17-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-21-2019 03-31-2019 10-Q
23 03-28-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-13-2017 12-31-2016 10-K
32 11-08-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 03-09-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.greenmarketreport.com/mdma-therapy-gets-support-from-prominent-research-group-as-fda-weighs-action/ The paper noted...

Core News & Articles

https://www.marijuanamoment.net/oregons-first-in-nation-psilocybin-industry-is-struggling-to-find-paying-customers-a-year-after...

 seelos-therapeutics-prices-11m-registered-direct-offering-and-concurrent-private-placement-at-246share

Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company...

 seelos-therapeutics-approves-1-for-8-reverse-stock-split-to-begin-trading-on-a-reverse-stock-split-adjusted-basis-at-the-opening-of-the-market-on-thursday-may-16-2024

Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company...

Core News & Articles

https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Ad...

 on-april-30-seelos-therapeutics-inc--announced-a-reduction-in-its-workforce-that-affected-33-of-its-current-employees-company-received-bid-notice-from-nasdaq-stock-market

- SEC Filing

 seelos-therapeutics-announces-strategic-focus-on-mental-health-initiatives-and-provides-an-update-on-current-discussions-of-potential-partnerships-and-collaboration-richard-pascoe-appointed-chairman-of-the-board

-Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing business development discussionsNEW YORK,...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 nasdaq-turns-higher-caleres-posts-upbeat-q4-results

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 50 points on Tuesday. The Dow...

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION